Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Philip Morris CR a.s. (PHPMF)
Prague, ON, CZ
Philip Morris CR a.s., through its subsidiary, Philip Morris Slovakia s.r.o., manufactures and markets tobacco products under the Marlboro, L&M, Chesterfield, Petra Klasik, Sparta, and RGD brands in the Czech Republic and the Slovak Republic. It also distributes smoke-free tobacco products under the HEETS name; IQOS tobacco heating systems; IQOS VEEV electronic cigarettes; VEEV One pods, an e-vapor product; and the Fiit and lil SOLID tobacco heating systems, and related accessories, as well as cigarettes. The company was founded in 1812 and is based in Prague, the Czech Republic. Philip Morris CR a.s. operates as a subsidiary of Philip Morris Holland Holdings B.V.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +0.00% | +5.69% | +0.00% | +4.00% | +24.46% | +29.24% | +31.88% | +31.88% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Tobacco: +5.3%+0.4% Q4'25: +1.2% (vs Q4'23)
-
EPS growth Tobacco: +18.8%-9.2% Q4'25: -15.2% (vs Q4'23)
-
FCF margin FCF growth · Tobacco: +9.5%+58.0% ★ Q4'25: +107.5% (vs Q4'23)
-
EBIT margin Tobacco: +20.5%+18.4% Q4'25: +19.1% (vs Q4'23)
-
ROIC Tobacco: +16.0%— Q4'25: -1,951.1% (vs Q4'23)
-
Share dilution Tobacco: +0.0%+0.0% Q4'25: +0.0% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Tobacco: 0.25×0.18× ★ Q4'25: 0.08× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
10.87B
est: 10.60B (+2.5%)
|
11.45B
est: 10.76B (+6.4%)
|
12.20B
est: 11.91B (+2.4%)
|
14.08B
est: 12.29B (+14.6%)
|
17.09B
est: 15.76B (+8.5%)
|
17.88B
est: 17.03B (+5.0%)
|
18.87B
est: 18.54B (+1.8%)
|
20.95B
est: 20.75B (+0.9%)
|
20.57B
est: 20.73B (-0.8%)
|
21.61B
est: 21.66B (-0.2%)
|
21.69B
est: 21.89B (-0.9%)
|
23.38B
23.38B – 23.38B
+6.8% YoY
|
24.47B
24.47B – 24.47B
+4.6% YoY
|
24.47B
24.47B – 24.47B
+0.0% YoY
|
25.55B
25.55B – 25.55B
+4.4% YoY
|
| EBITDA |
3.62B
est: 2.74B (+32.1%)
|
4.02B
est: 2.78B (+44.5%)
|
4.94B
est: 3.08B (+60.2%)
|
5.46B
est: 3.18B (+71.9%)
|
5.81B
est: 4.07B (+42.6%)
|
5.19B
est: 4.40B (+17.8%)
|
5.15B
est: 4.79B (+7.4%)
|
5.33B
est: 5.37B (-0.6%)
|
4.95B
est: 5.36B (-7.6%)
|
5.07B
est: 5.28B (-4.0%)
|
4.69B
est: 5.34B (-12.1%)
|
5.70B
5.70B – 5.70B
+6.8% YoY
|
5.97B
5.97B – 5.97B
+4.6% YoY
|
5.97B
5.97B – 5.97B
+0.0% YoY
|
6.23B
6.23B – 6.23B
+4.4% YoY
|
| EBIT |
3.21B
est: 2.38B (+34.8%)
|
3.47B
est: 2.41B (+43.9%)
|
4.34B
est: 2.67B (+62.5%)
|
4.82B
est: 2.76B (+74.8%)
|
5.11B
est: 3.53B (+44.5%)
|
4.56B
est: 3.82B (+19.5%)
|
4.41B
est: 4.16B (+6.0%)
|
4.66B
est: 4.65B (+0.1%)
|
4.28B
est: 4.65B (-8.0%)
|
4.37B
est: 4.55B (-4.0%)
|
3.99B
est: 4.60B (-13.2%)
|
4.91B
4.91B – 4.91B
+6.8% YoY
|
5.14B
5.14B – 5.14B
+4.6% YoY
|
5.14B
5.14B – 5.14B
+0.0% YoY
|
5.37B
5.37B – 5.37B
+4.4% YoY
|
| Net Income |
2.57B
est: 3.37B (-23.7%)
|
2.77B
est: 3.04B (-9.0%)
|
3.48B
est: 3.07B (+13.6%)
|
3.84B
est: 3.46B (+10.9%)
|
4.02B
est: 4.03B (-0.3%)
|
3.53B
est: 3.88B (-9.1%)
|
3.52B
est: 3.60B (-2.2%)
|
3.64B
est: 3.68B (-1.2%)
|
3.34B
est: 3.29B (+1.6%)
|
3.34B
est: 3.71B (-9.8%)
|
3.04B
est: 3.52B (-13.8%)
|
3.80B
3.80B – 3.80B
+7.9% YoY
|
4.05B
4.05B – 4.05B
+6.5% YoY
|
3.85B
3.85B – 3.85B
-4.9% YoY
|
4.29B
4.29B – 4.29B
+11.6% YoY
|
| SGA |
1.98B
est: 2.48B (-20.4%)
|
1.94B
est: 2.52B (-23.1%)
|
1.83B
est: 2.79B (-34.4%)
|
3.20B
est: 2.88B (+11.1%)
|
3.71B
est: 3.69B (+0.6%)
|
4.16B
est: 3.99B (+4.4%)
|
3.98B
est: 4.34B (-8.4%)
|
4.89B
est: 4.86B (+0.7%)
|
4.96B
est: 4.85B (+2.2%)
|
5.46B
est: 5.17B (+5.5%)
|
5.55B
est: 5.23B (+6.3%)
|
5.58B
5.58B – 5.58B
+6.8% YoY
|
5.84B
5.84B – 5.84B
+4.6% YoY
|
5.84B
5.84B – 5.84B
+0.0% YoY
|
6.10B
6.10B – 6.10B
+4.4% YoY
|
| EPS |
936.00
est: 1,226.35 (-23.7%)
|
1,008.00
est: 1,107.00 (-8.9%)
|
1,269.00
est: 1,117.04 (+13.6%)
|
1,397.09
est: 1,259.38 (+10.9%)
|
1,464.48
est: 1,468.46 (-0.3%)
|
1,284.52
est: 1,413.65 (-9.1%)
|
1,280.87
est: 1,310.12 (-2.2%)
|
1,324.23
est: 1,340.42 (-1.2%)
|
1,217.85
est: 1,198.50 (+1.6%)
|
1,218.00
est: 1,350.34 (-9.8%)
|
1,106.00
est: 1,282.17 (-13.7%)
|
1,384.05
1,384.05 – 1,384.05
+7.9% YoY
|
1,473.83
1,473.83 – 1,473.83
+6.5% YoY
|
1,401.81
1,401.81 – 1,401.81
-4.9% YoY
|
1,564.58
1,564.58 – 1,564.58
+11.6% YoY
|
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Fidelity All-American Equity ETF FCAM.NE | 1.15% | 2.64M | 0.39% |
| 2 | Fidelity All-in-One Growth ETF FGRO.NE | 0.46% | 15.95M | 0.42% |
| 3 | Fidelity All-in-One Balanced ETF FBAL.NE | 0.33% | 21.71M | 0.41% |
| 4 | Fidelity All-in-One Conservative ETF FCNS.NE | 0.22% | 3.43M | 0.40% |
| 5 | iShares MSCI Emerging Markets Small-Cap ETF EEMS | 0.03% | 98.2K | 0.72% |
| 6 | iShares MSCI EM Small Cap UCITS ETF IEMS.L | 0.02% | 77.1K | 0.74% |
| 7 | State Street SPDR MSCI Emerging Markets Small Cap UCITS ETF EMSD.L | 0.02% | 95.7K | 0.55% |
| 8 | Dimensional - Emerging Markets High Profitability ETF DEHP | 0.01% | 43.9K | 0.44% |
| 9 | Dimensional - Emerging Markets ex China Core Equity ETF DEXC | 0.01% | 24.2K | 0.56% |
| 10 | iShares Core MSCI EM IMI UCITS ETF EIMU.L | 0.01% | 101.7K | 0.18% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Cemal Berk Temuroglu | Director of Commercial Operations & Director | — | male |
| Dimitrios Karampis | Director of People & Culture | — | male |
| Eugenia Panato | Financial Director & Director | — | female |
| Fabio Acosta | Chairman of the Board & Chief Executive Officer | — | male |
| Maurizio Lionetti | Director of Finance & Director | — | male |
| Petr Sebek | Director of External Affairs & Director | — | male |
| Serhan Kilic | Production Director & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for PHPMF
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
